Apax Partners, the private equity firm, has called off talks about a £400m bid for Alliance Pharma, the London-listed company which owns brands including Forceval vitamin supplements and Nizoral shampoo.

Sky News has learnt that Apax was in discussions until this week about an offer for the company, which has a market value of about £320m.

It was unclear on Wednesday why the buyout firm had stepped away from the talks, or whether any other suitors were engaged with Alliance Pharma.

Discussions with Apax are said to have been underway for some time.

Alliance Pharma holds the rights to approximate 80 consumer healthcare brands and prescription medicines.

Others in its portfolio include Amberen, Hydromol and MacuShield.

In its annual results in March, the company said trading “had not been as strong as had been anticipated”, adding that revenue growth had been affected by COVID-19 lockdowns in China.

Inflation eases but still remains above 10% as food costs at 45-year high

Food prices will remain stubbornly high for a while but there is good news on inflation ahead

Cost of living news latest: UK now an outlier among major economies on inflation – and it will mean even higher interest rates

Alliance Pharma’s shares have halved during the last 12 months, and were trading at around 60.3p on Wednesday afternoon.

The talks have emerged during a flurry of takeover bids for London-listed companies, with THG, Dechra and Wood Group all having received approaches in recent weeks.

Apax and Alliance Pharma both declined to comment.

Related posts:

Former Unilever veteran Banga lined up to lead government agency UKGI Shell plans to install 50,000 electric vehicle charging points across UK Banking tech provider ThoughtMachine lands ‘unicorn’ status with new funding Bank of England names successor to Andy Haldane as chief economist Wizz Air gives flight crews December deadline for COVID jab EasyJet sees softening of bookings as COVID restrictions grow amid omicron uncertainty Emirates could be taxiing toward an IPO take-off – but will it fly with investors? Help vaccinate poor countries or face more new COVID variant shocks, rich economies told BT faces strike vote while Tesco agrees new pay deal The Energy Security Strategy has something in it to disappoint everyone Drivers warned to expect long delays as millions plan Easter getaway Petrol prices fall to lowest level in nearly a year – but some areas are benefitting more than others